Five Prime Therapeutics Enters Collaboration Agreement With Bristol-Myers
October 15, 2015 at 10:36 AM EDT
Shares of Five Prime Therapeutics are up 62% after entering into a collaboration agreement with Bristol-Myers. Both companies entered into this agreement to collaborate on Five Prime's anti-body program for the treatment of cancer.
